Matthew S. Sutton

569 total citations
10 papers, 82 citations indexed

About

Matthew S. Sutton is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Matthew S. Sutton has authored 10 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Matthew S. Sutton's work include HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS Research and Interventions (3 papers). Matthew S. Sutton is often cited by papers focused on HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS Research and Interventions (3 papers). Matthew S. Sutton collaborates with scholars based in United States, Australia and Brazil. Matthew S. Sutton's co-authors include Shelby L. O’Connor, Dominic Paquin‐Proulx, Alexis J. Balgeman, Natália B. Cerqueira, Thomas C. Friedrich, Andrea M. Weiler, Esper G. Kallás, Douglas F. Nixon, Cássia Gisele Terrassani Silveira and Karina I. Carvalho and has published in prestigious journals such as Journal of Virology, Science Advances and Science Translational Medicine.

In The Last Decade

Matthew S. Sutton

7 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew S. Sutton United States 5 52 40 37 19 14 10 82
Mathieu Claireaux Netherlands 6 91 1.8× 43 1.1× 33 0.9× 37 1.9× 20 1.4× 15 142
Daniel C. Douek United States 3 78 1.5× 75 1.9× 30 0.8× 23 1.2× 21 1.5× 5 120
Yelizaveta Rassadkina United States 6 34 0.7× 54 1.4× 33 0.9× 12 0.6× 27 1.9× 7 98
Vanessa Naidoo South Africa 4 66 1.3× 58 1.4× 67 1.8× 30 1.6× 41 2.9× 5 138
Claudia Carbone United States 3 41 0.8× 76 1.9× 42 1.1× 17 0.9× 39 2.8× 3 107
Joumana Zeidan Canada 4 64 1.2× 39 1.0× 24 0.6× 22 1.2× 9 0.6× 5 94
Poonam Pegu United States 4 33 0.6× 40 1.0× 19 0.5× 23 1.2× 9 0.6× 5 61
Karen Dunn United States 4 32 0.6× 28 0.7× 23 0.6× 16 0.8× 21 1.5× 4 92
Maxime Beretta France 5 31 0.6× 25 0.6× 32 0.9× 67 3.5× 17 1.2× 8 97

Countries citing papers authored by Matthew S. Sutton

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Sutton more than expected).

Fields of papers citing papers by Matthew S. Sutton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Sutton. The network helps show where Matthew S. Sutton may publish in the future.

Co-authorship network of co-authors of Matthew S. Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Sutton. A scholar is included among the top collaborators of Matthew S. Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Sutton. Matthew S. Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gardner, Christina L., S. Pletnev, Jinny L. Liu, et al.. (2025). Demonstration of in vivo efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodies. Journal of Virology. 100(1). e0187525–e0187525.
2.
Callahan, Victoria, Matthew S. Sutton, Christina L. Gardner, et al.. (2025). High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies. Science Translational Medicine. 17(812). eadt9853–eadt9853.
3.
Peters, Joshua M., Edward B. Irvine, Jacob M. Rosenberg, et al.. (2025). High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways. Science Advances. 11(1). eadq8229–eadq8229. 4 indexed citations
4.
Sutton, Matthew S., Allison N. Bucşan, Megha Kamath, et al.. (2024). Antibody-mediated depletion of select leukocyte subsets in blood and tissue of nonhuman primates. Frontiers in Immunology. 15. 1359679–1359679. 1 indexed citations
5.
Moriarty, Ryan V., Matthew S. Sutton, Vanessa Venturi, et al.. (2021). Validation of multiplex PCR sequencing assay of SIV. Virology Journal. 18(1). 21–21.
6.
Sutton, Matthew S., Amy Ellis, Alexis J. Balgeman, et al.. (2019). CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 93(15). 7 indexed citations
7.
Sutton, Matthew S., Amy Ellis, Ryan V. Moriarty, et al.. (2018). Acute-Phase CD4 + T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 92(21). 8 indexed citations
8.
Paquin‐Proulx, Dominic, Priscilla R. Costa, Cássia Gisele Terrassani Silveira, et al.. (2018). Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells. Frontiers in Immunology. 9. 1394–1394. 32 indexed citations
9.
Sutton, Matthew S., Charles M. Burns, Andrea M. Weiler, et al.. (2016). Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV. Journal of Virology. 90(12). 5541–5548. 10 indexed citations
10.
Longo, Nancy S., Matthew S. Sutton, Andrea R. Shiakolas, et al.. (2016). Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding. Journal of Virology. 90(23). 10574–10586. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026